Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States

By sjmartinez • May 8, 2024

Lurain K, Zarif TE, Ramaswami R, Nassar AH, Adib E, Abdel-Wahab N, Chintapally N, Drolen CE, Feldman T, Haykal T, Nebhan CA, Kambhampati S, Li M, Mittra A, Lorentsen M, Kim C, Drakaki A, Morse M, Johnson DB, Mangla A, Dittus C, Ravi P, Baiocchi RA, Chiao EY, Rubinstein PG, Yellapragada SV, LaCasce AS, Sonpavde GP, Naqash AR, Herrera AF. Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States. Clin Lymphoma Myeloma Leuk. 2024 Apr 5:S2152-2650(24)00134-4. doi: 10.1016/j.clml.2024.03.011. Epub ahead of print. PMID: 38714474.

Tags: Anti-PD-1, checkpoint inhibitors, General Internal Medicine, Hematology/Oncology, HIV/AIDS, Publications, Resident

A Unique Case of a Mildly Symptomatic Patient With Severe Hypokalemia Secondary to Furosemide

Dao KT, Dhillon A, Uddin SS, Eppanapally S, Lai H. A Unique Case of a Mildly Symptomatic Patient With Severe Hypokalemia Secondary to Furosemide. J[...]

Advancements in Spinal Cord Injury Rehabilitation

Eapen BC. Advancements in Spinal Cord Injury Rehabilitation. Phys Med Rehabil Clin N Am. 2025 Feb;36(1):xiii-xiv. doi: 10.1016/j.pmr.2024.09.002. Epub 2024 Oct 18. PMID: 39567042.

Higher-order disease interactions in multimorbidity measurement: marginal benefit over additive disease summation

Wei MY, Tseng CH, Kang AJ. Higher-order disease interactions in multimorbidity measurement: marginal benefit over additive disease summation. J Gerontol A Biol Sci Med Sci.[...]